Replimune Group (REPL) News Today $8.93 -0.44 (-4.70%) Closing price 04:00 PM EasternExtended Trading$8.80 -0.13 (-1.44%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock REPL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Replimune Group (NASDAQ:REPL) Stock Price Up 5.4% - Here's WhyReplimune Group (NASDAQ:REPL) Shares Up 5.4% - Here's What HappenedMay 30 at 12:41 PM | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Nuveen Asset Management LLCNuveen Asset Management LLC increased its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 108.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 667,634 shares of the company's stockMay 30 at 3:38 AM | marketbeat.comReplimune to Present at the 2025 Jefferies Global Healthcare ConferenceMay 29 at 8:00 AM | globenewswire.comHC Wainwright Estimates Replimune Group Q3 EarningsReplimune Group, Inc. (NASDAQ:REPL - Free Report) - HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for Replimune Group in a report released on Friday, May 23rd. HC Wainwright analyst R. Burns anticipates that the company will post earnings of ($0.66) per share for the quartMay 27 at 2:07 AM | marketbeat.comAnalysts Offer Predictions for Replimune Group Q1 EarningsMay 27 at 1:57 AM | americanbankingnews.comLeerink Partnrs Estimates Replimune Group Q1 EarningsReplimune Group, Inc. (NASDAQ:REPL - Free Report) - Leerink Partnrs issued their Q1 2026 EPS estimates for shares of Replimune Group in a research note issued on Thursday, May 22nd. Leerink Partnrs analyst J. Chang forecasts that the company will post earnings of ($0.70) per share for the quarterMay 27 at 1:51 AM | marketbeat.comReplimune’s SWOT analysis: biotech firm’s stock poised for growth amid FDA reviewMay 26, 2025 | investing.comReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Woodline Partners LPWoodline Partners LP grew its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 156.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 854,309 shares of the company's stock after purchasiMay 25, 2025 | marketbeat.comMillennium Management LLC Acquires 34,841 Shares of Replimune Group, Inc. (NASDAQ:REPL)Millennium Management LLC raised its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 3.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,189,662 shares of the company's stock afterMay 25, 2025 | marketbeat.comReplimune Group (NASDAQ:REPL) Shares Gap Up - Here's WhyReplimune Group (NASDAQ:REPL) Shares Gap Up - Here's WhyMay 24, 2025 | marketbeat.comTraders Buy High Volume of Replimune Group Call Options (NASDAQ:REPL)Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) was the target of unusually large options trading on Thursday. Stock investors acquired 5,508 call options on the stock. This is an increase of 652% compared to the typical daily volume of 732 call options.May 24, 2025 | marketbeat.comEarnings call transcript: Replimune Q1 2025 sees stock drop post-earningsMay 24, 2025 | uk.investing.comREPLIMUNE GROUP Earnings Results: $REPL Reports Quarterly EarningsMay 24, 2025 | nasdaq.comReplimune Group Sees Unusually Large Options Volume (NASDAQ:REPL)May 24, 2025 | americanbankingnews.comReplimune Group, Inc. (NASDAQ:REPL) Q4 2025 Earnings Call TranscriptMay 23, 2025 | insidermonkey.comEmily Luisa Hill Sells 2,535 Shares of Replimune Group, Inc. (NASDAQ:REPL) StockMay 23, 2025 | insidertrades.comPoint72 Asset Management L.P. Buys Shares of 283,966 Replimune Group, Inc. (NASDAQ:REPL)Point72 Asset Management L.P. bought a new stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 283,966 shares of the company's stock, valued at approximately $3,May 23, 2025 | marketbeat.comQ4 2025 Replimune Group Inc Earnings CallMay 23, 2025 | uk.finance.yahoo.comReplimune Group, Inc. (REPL) Q4 2025 Earnings Call TranscriptMay 22, 2025 | seekingalpha.comReplimune Reports Fiscal Fourth Quarter and Year End 2025 Financial Results and Provides Corporate UpdateMay 22, 2025 | globenewswire.comNorthern Trust Corp Acquires 40,134 Shares of Replimune Group, Inc. (NASDAQ:REPL)Northern Trust Corp increased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 589,635 shares of the company's stock after purchasing an additMay 22, 2025 | marketbeat.comVelan Capital Investment Management LP Acquires Shares of 181,367 Replimune Group, Inc. (NASDAQ:REPL)Velan Capital Investment Management LP acquired a new stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 181,367 shares of the company's stock, valuMay 21, 2025 | marketbeat.comSoleus Capital Management L.P. Acquires Shares of 262,500 Replimune Group, Inc. (NASDAQ:REPL)Soleus Capital Management L.P. acquired a new stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 262,500 shares of the company's stockMay 21, 2025 | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Stock Holdings Lifted by Tang Capital Management LLCTang Capital Management LLC raised its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 125.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,700,000 shares of the companyMay 20, 2025 | marketbeat.comRTW Investments LP Grows Stake in Replimune Group, Inc. (NASDAQ:REPL)RTW Investments LP boosted its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 82.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,065,010 shares of the company's stock after purchasingMay 18, 2025 | marketbeat.comReplimune Group: Analysts Are More Optimistic Than The MarketMay 16, 2025 | seekingalpha.com950,000 Shares in Replimune Group, Inc. (NASDAQ:REPL) Purchased by MPM Bioimpact LLCMPM Bioimpact LLC acquired a new position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 950,000 shares of the company's stock, valued at approximately $11,504,000. Replimune Group makesMay 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Has $10.53 Million Stock Holdings in Replimune Group, Inc. (NASDAQ:REPL)Parkman Healthcare Partners LLC increased its position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 13.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 869,759 sMay 16, 2025 | marketbeat.comReplimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor DayMay 16, 2025 | globenewswire.comReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. boosted its holdings in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 12.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 972,575 shares of the company's stock after purchasing an additional 104,892 shares during the peMay 16, 2025 | marketbeat.comOmega Fund Management LLC Sells 486,116 Shares of Replimune Group, Inc. (NASDAQ:REPL)Omega Fund Management LLC decreased its holdings in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 19.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,975,203 shares of the comMay 15, 2025 | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Shares Purchased by J. Goldman & Co LPJ. Goldman & Co LP increased its position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 639.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,683 shares of the compMay 14, 2025 | marketbeat.comJane Street Group LLC Has $3.83 Million Stock Position in Replimune Group, Inc. (NASDAQ:REPL)Jane Street Group LLC lifted its stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 20.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 316,287 shares of the company's stock after acquiringMay 13, 2025 | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP grew its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 42.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 778,163 shares of the company's stock afterMay 12, 2025 | marketbeat.comFcpm Iii Services B.V. Has $48.09 Million Position in Replimune Group, Inc. (NASDAQ:REPL)Fcpm Iii Services B.V. reduced its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 18.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,970,668 shares of the company's stock afterMay 11, 2025 | marketbeat.com172,202 Shares in Replimune Group, Inc. (NASDAQ:REPL) Bought by Crestline Management LPCrestline Management LP purchased a new stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 172,202 shares of the company's stock, valued at approximately $2,0May 10, 2025 | marketbeat.comReplimune Group (REPL) Projected to Post Earnings on ThursdayReplimune Group (NASDAQ:REPL) will be releasing its Q4 2025 earnings before the market opens on Thursday, May 15. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-15-replimune-group-inc-stock/)May 10, 2025 | marketbeat.comReplimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 9, 2025 | globenewswire.comBraidwell LP Has $17.89 Million Position in Replimune Group, Inc. (NASDAQ:REPL)Braidwell LP trimmed its stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 51.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,477,102 shares of the company's stock after selling 1,593,735 shares duringMay 8, 2025 | marketbeat.comSibylla Biotech Appoints Former Bayer CEO, Dieter Weinand, as Chairman of the Board of DirectorsMay 8, 2025 | globenewswire.comReplimune Group, Inc. (NASDAQ:REPL) Stock Holdings Cut by Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC lessened its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 71.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 163,300 shares of the company's stock after selling 408,927 sharesMay 8, 2025 | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Buy" by AnalystsReplimune Group, Inc. (NASDAQ:REPL - Get Free Report) has earned an average rating of "Buy" from the eight analysts that are currently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recomMay 8, 2025 | marketbeat.comBoxer Capital Management LLC Buys Shares of 1,796,341 Replimune Group, Inc. (NASDAQ:REPL)Boxer Capital Management LLC purchased a new position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,796,341 shares of the companyMay 4, 2025 | marketbeat.comInvesco Ltd. Sells 92,952 Shares of Replimune Group, Inc. (NASDAQ:REPL)Invesco Ltd. cut its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 51.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 88,006 shares of the company's stockMay 4, 2025 | marketbeat.comReplimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Wells Fargo & Company MNWells Fargo & Company MN grew its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 102.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 77,371 shares of the company's stock after buying an additional 39,1May 2, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Purchases 1,083,633 Shares of Replimune Group, Inc. (NASDAQ:REPL)Price T Rowe Associates Inc. MD increased its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 11.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,962,883 shares of the company's stock after buyingApril 29, 2025 | marketbeat.comReplimune: Scope Goes Beyond That Of RP1 Oncolytic Targeting For MelanomaApril 28, 2025 | seekingalpha.comRenaissance Technologies LLC Buys 49,200 Shares of Replimune Group, Inc. (NASDAQ:REPL)Renaissance Technologies LLC lifted its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 45.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 156,936 shares of the company's stock after purchasing an additional 49,200 shares during the pApril 28, 2025 | marketbeat.comReplimune Group (NASDAQ:REPL) Trading Down 2.9% - Should You Sell?Replimune Group (NASDAQ:REPL) Shares Down 2.9% - Time to Sell?April 24, 2025 | marketbeat.comDiadema Partners LP Purchases Shares of 114,000 Replimune Group, Inc. (NASDAQ:REPL)Diadema Partners LP acquired a new position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 114,000 shares of the company's stock, valued at apprApril 24, 2025 | marketbeat.com Get Replimune Group News Delivered to You Automatically Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter. Email Address REPL Media Mentions By Week REPL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REPL News Sentiment▼1.100.87▲Average Medical News Sentiment REPL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REPL Articles This Week▼214▲REPL Articles Average Week Get Replimune Group News Delivered to You Automatically Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MoonLake Immunotherapeutics News Immunovant News HUTCHMED News Ascentage Pharma Group International News Xenon Pharmaceuticals News Organon & Co. News Amneal Pharmaceuticals News ImmunityBio News Apellis Pharmaceuticals News Mirum Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REPL) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REPL Stock Free REPL Stock Alerts